Skip to content
  • Sunday, 26 July 2026
  • 1:44 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics
Pharmaceutical R&D

Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics

Teuku Ryan Jul 22, 2026 0

The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…

Read More
Pharmaceutical R&D

The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties

Teuku Ryan Jul 20, 2026 0

The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…

Read More
Laboratory Automation & Robotics

Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access

Lana Keisha Jun 4, 2026 0

In a landmark decision poised to reshape the landscape of diabetes and obesity management, Health Canada has granted authorization to…

Read More
Advanced Materials Science

Revolutionary Solar-Powered Desalination Technology Offers a Sustainable Path to Global Clean Water Access and Critical Mineral Recovery

Nila Kartika Wati May 31, 2026 0

The United Nations recently reported a sobering statistic that highlights a burgeoning humanitarian crisis: approximately 2.2 billion people across the…

Read More
Clinical Diagnostics & Pathology

Decoding Legal Trends and Emerging Considerations in Laboratory Data with a Focus on Value, Clarifying Ownership and Access Rights, Protecting Data, and Strategically Monetizing Information

Reynand Amr Wu May 31, 2026 0

Cleveland, OH – In a significant event for the legal and business communities, Elizabeth Sullivan, JD, and Emily Johnson, JD,…

Read More
Pharmaceutical R&D

NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK

Teuku Ryan May 29, 2026 0

In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Laboratory Models

Reynand Amr Wu May 24, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with West Virginia emerging as a key region illustrating this…

Read More
Clinical Diagnostics & Pathology

Walk-In Lab Testing Expands Patient Access and Autonomy in West Virginia

Reynand Amr Wu May 17, 2026 0

The landscape of healthcare is undergoing a profound transformation, with West Virginia emerging as a focal point for a significant…

Read More
Clinical Diagnostics & Pathology

Labcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National Access

Reynand Amr Wu May 16, 2026 0

The landscape of clinical diagnostics is poised for a significant transformation following the announcement of a strategic collaboration between Labcorp,…

Read More
Laboratory Automation & Robotics

Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Novo Nordisk Patent Lapse, Paving Way for Enhanced Access and Affordability

Lana Keisha May 13, 2026 0

In a landmark decision poised to significantly reshape the pharmaceutical landscape for diabetes and obesity management, Health Canada has granted…

Read More

Posts pagination

1 2 3
American Diabetes Association Conference Sees Landmark GLP-1 Trial Results Amidst Unprecedented Controversy Over Researcher RemovalExpanding Screening for Type 1 Diabetes in Children Could Identify More CasesInflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Clonal Hematopoiesis and Myelodysplastic SyndromesOptovolution: Harnessing Light and Evolution for Dynamic Proteins and Cellular Computation
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ